Meritain Eldorado policies
Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
10 policies name Q5115, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0979-Tafasitamab-cxix (Monjuvi) | 0979 · Commercial | 6 | Original policy ↗ |
| 0955-Polatuzumab vedotin-piiq (Polivy) | 0955 · Commercial | 34 | Original policy ↗ |
| 0845-Carfilzomib (Kyprolis) | 0845 · Commercial | 38 | Original policy ↗ |
| 0905-Secukinumab (Cosentyx) | 0905 · Commercial | 39 | Original policy ↗ |
| 0818-Belimumab (Benlysta) | 0818 · Commercial | 47 | Original policy ↗ |
| Abatacept (Orencia) | 0720 · Commercial | 64 | Original policy ↗ |
| Rituximab | 0314 · Commercial | 74 | Original policy ↗ |
| Polymerase Chain Reaction Testing: Selected Indications | 0650 · Commercial | 182 | Original policy ↗ |
| Participating provider precertification list for Aetna® | 1013000-01-35 · Effective Nov 1, 2025 · Commercial | 1,389 | Original policy ↗ |
| Participating provider precertification list for Aetna® | Effective Jan 1, 2026 · Commercial | 1,440 | Original policy ↗ |